Advertisement
Document › Details
Bespark Bio GmbH. (10/15/24). "News: aws SEED!".
Region | Austria | |
Organisation | Bespark Bio GmbH (bespark*bio) | |
Organisation 2 | Österreichische Forschungsförderungsgesellschaft mbH (FFG) | |
Group | Austria (govt) | |
Product | biopharmaceutical production technology (biomanufacturing) | |
Product 2 | business development (state/region) | |
Index term | Bespark Bio–Austria (govt): grant, 202409 FFG grant €381.5k | |
We are excited to announce that bespark*bio has successfully secured Seed funding from aws (Austria Wirtschaftsservice), marking a major milestone in our journey!
In 2023, aws PreSeed funding gave us the vital support to launch the development of our groundbreaking Gene Therapy Technology. That backing enabled us to make strong progress and generate promising data, validating our approach.
Now, with Seed funding in place, we’re accelerating the development of cutting-edge technology with the potential to transform the treatment of genetic disorders.
We are deeply grateful to aws for their continued support in helping us bring this vision closer to reality!
Record changed: 2024-11-25 |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top